Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

PFE
Pfizer Inc.
stock NYSE

At Close
2/3/2023 3:59:56 PM EST
44.06USD-0.643%(-0.29)23,741,990
43.12Bid   44.91Ask   1.79Spread IEX
Pre-market
2/3/2023 9:29:30 AM EST
44.39USD+0.113%(+0.05)533
After-hours
2/3/2023 4:02:30 PM EST
44.06USD+0.034%(+0.02)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
247.295B
Headquarters
New York, USA
Industry
Drug Manufacturers-General
Next Earnings
2023-05-02 (85d)
Last Dividend
2023-01-260.410
Last Split
1999-07-013for1
Related
AMGNAZNGSKNVSABTBMYJNJLLYMRKMYLXLV
PFE Stats
Avg. Vol. 10 Day
28,650,317
Avg. Vol. 30 Day
26,582,376
Dividend Yield
3.615%
Dividend Rate (ttm)
1.589
Employees
79,000
Market Cap
247,294,571,928
Shares Out.
5,613,314,537
Float
5,606,129,494
P/E Ratio
8.29
EPS (ttm)
5.190
On/Off Exchange
58%/42%
6 Month Beta
0.58
1 Year Beta
0.53
2 Year Beta
0.42
3 Year Beta
0.58
52 Week Low
40.72
52 Week High
54.46
SMA50
47.87
SMA200
47.05
1 Week
+1.16%
1 Month
-11.29%
3 Month
-6.70%
6 Month
-10.55%
1 Year
-16.88%
2 Year
+26.16%
5 Year
+27.07%
Jan 31, 2022
07:47AM EST  Pfizer Inc. (PFE) and Ionis Pharmaceuticals, Inc. (IONS) announced the discontinuation of the Pfizer-led clinical development program for vupanorsen, an investigational antisense therapy. Also, Pfizer will return development rights to vupanorsen to Ionis.   RTTNews
07:16AM EST  Pfizer And Ionis Announce Discontinuation Of Vupanorsen Clinical Development Program   Benzinga
07:08AM EST  Pfizer, Ionis Announce Discontinuation Of Vupanorsen Clinical Program For CV Risk Reduction And Hypertriglyceridemia   RTTNews
07:05AM EST  Pfizer and Ionis announce discontinuation of vupanorsen clinical development   PR Newswire
05:29AM EST  Pfizer and Alex Therapeutics Announced a Strategic Commercial Partnership to Provide Evidence-based Digital Therapeutics to Patients, Starting in Germany   Benzinga
More News
Profile
Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. It strives to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with its responsibility as one of the world's premier innovative biopharmaceutical companies, it collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, it has worked to make a difference for all who rely on it. It routinely posts information that may be important to investors on its website at www.Pfizer.com.

PFE Stock Summary

Pfizer Inc. (NYSE:PFE) stock price today is $44.06, and today's volume is 23,741,990. PFE is down -0.643% today. The 30 day average volume is 26,582,376. PFE market cap is 247.295B with 5,613,314,537 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC